The global Conbercept Market is experiencing strong growth as the prevalence of retinal diseases continues to rise worldwide. Conbercept is a recombinant fusion protein that functions as an anti-vascular endothelial growth factor (anti-VEGF) therapy, primarily used in the treatment of age-related macular degeneration (AMD), diabetic macular edema (DME), pathological myopia, and other retinal...